# Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

> **NCT00333736** · PHASE2 · COMPLETED · sponsor: **Canadian Immunodeficiency Research Collaborative** · enrollment: 337 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DEVICE:** Biojector

## Key facts

- **NCT ID:** NCT00333736
- **Lead sponsor:** Canadian Immunodeficiency Research Collaborative
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-09
- **Final completion:** 2008-09
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2012-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333736, "Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00333736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*